STAR and endometrial cancer: The mechanism accounting for estrogen sensitive ovarian and endometrial cancers, connecting mutations in the StAR gene, remains unclear, and may involve one or more compensatory event(s), including involvement of StAR related lipid transfer proteins 3-6 (STARD3-6) and/or other factors involved in cholesterol trafficking [55,56].